SlideShare a Scribd company logo
1 of 24
TETANUS
Prepared by:
SAgun PAudel
Health Assistant
Student of BPH @ LA GRANDEE International college, Simalchour
Pokhara, Nepal
Presented with:
Rajeev Nepal
5/11/2012 Disease Presentation- TETANUS 1
Definition:
5/11/2012 Disease Presentation- TETANUS 2
Tetanus is a acute bacterial disease caused by the
neurotoxin tetanospasmin elaborated by
Clostridium tetani. and characterized by a
prolonged contraction of skeletal muscle fibers.
It is also called lockjaw.
Causative organism:
 Clostridium tetani is a Gram-positive, obligate
anaerobic, spore bearing and flagellate organism.
 produce a potent exotoxin called tetanospasmin.
spores are resistant to heat and most antiseptics.
5/11/2012 Disease Presentation- TETANUS 3
epidemiology:
5/11/2012 Disease Presentation- TETANUS 4
 Tetanus is an international health problem, as spores
are ubiquitous. The disease occurs almost exclusively
in persons who are unvaccinated or inadequately
immunized.
 Tetanus occurs worldwide but is more common in hot,
damp climates with soil rich in organic matter.
 More common in developing and under developing
countries.
 More prevalent in industrial establishment, where
agricultures workers are employed.
 Tetanus neonatorum is common due to lack of MCH
care.
Global burden:
5/11/2012 Disease Presentation- TETANUS 5
 Tetanus, particularly the neonatal form a significant
public health problem in non-industrialized countries.
 The World Health Organization estimates that
59,000 newborns worldwide died in 2008 as a result
of neonatal tetanus.
In Nepal :
5/11/2012 Disease Presentation- TETANUS 6
 In late 2005,Nepal demonstrated through surveys that it
had reached the WHO criterion for having eliminated
neonatal tetanus, i.e. NT cases occurred at a rate of less
than 1 per 1000 live births in every district.
Strategies:
 clean delivery
 routine immunization
 supplemental immunization campaigns
 surveillance
Some facts;
5/11/2012 Disease Presentation- TETANUS 7
 Initiation of EPI in 1979 [3 districts]
 1989 in 75 districts
 DPT and TT vaccines from 1981.
years TT+2 COVERAGE
1993–1995 33%
1996–2000 45%
1999 65%
INCUBATION PERIOD:
5/11/2012 Disease Presentation- TETANUS 8
 Usually incubation period ranges from 3-21 days but
can range from the day of injury to several months.
 Average incubation period is 10 days.
 Depends on character, location, and extent of
wound.
Mode of transmission:
5/11/2012 Disease Presentation- TETANUS 9
 Infection is acquired by contamination of wounds with
Clostridium tetani spores. a tiny breach in skin or mucosa
(e.g.. Skin abrasion, punctured wounds, burns, animal
bites, unsterile surgery, aseptic abortion, unsterile
instruments to cut umbilical cord etc.) leads to introduce
of spores.
 the spores are widely distributed in the intestines and
faeces of many non-human animals such as horses,
sheep, cattle, dogs, cats, rats, guinea pigs, and chickens.
 Tetanus is not spread from person to person.
Pathogenesis:
5/11/2012 Disease Presentation- TETANUS 10
 Tetanus begins when spores of Clostridium tetani enter
damaged tissue.
The spores transform into rod-shaped bacteria and produce
the neurotoxin tetanospasmin (also known as tetanus
toxin).
This toxin is inactive inside the bacteria, but when the
bacteria die, toxin is released and activated by proteases.
Finally it interferes with neurotransmission at spinal synapses
of inhibitory neurons.
This results to uncontrolled spasms and reflexes.
Clinical features:
 Pain and tingling at the site of wound.
 Pain in neck, back and abdomen.
 Opisthotonos position.
 Risus sardonicus (Mouth kept slightly
open)
 Spasm of pharyngeal muscles.
 Lock jaw (reflex trismus).
 Dysphasia.
 Acute asphyxia.
 Refusal of feeding and excessive
crying.
 Other symptoms like fever, headache,
etc
5/11/2012 Disease Presentation- TETANUS 11
Diagnosis:
5/11/2012 Disease Presentation- TETANUS 12
 There are currently no blood tests that can be
used to diagnose tetanus.
 clinical presentation of patient associated with
tetanus are the essential factors of diagnosis.
 history of injury and possible contamination.
Treatment:
5/11/2012 Disease Presentation- TETANUS 13
 Injection tetanus toxoid 0.5ml intramuscularly.
 Passive immunization with human anti - tetanospasmin
immunoglobulin.
 Local wound care:
o Incision & drainage of pus.
o Debridement (Removal of necrotic tissues & foreign
bodies)
o Wound should be open.
Treatment:
 Control of spasm:
o Injection diazepam 0.1-0.2mg/ kg.
o Paralyze & ventilate.
 Antibiotics:
o Broad spectrum antibiotics to treat or prevent
infection.
 Supportive care:
o Isolation in a quit dark room.
o Maintain fluid, nutrition, and electrolytes.
o Oxygen inhalation if required.
5/11/2012 Disease Presentation- TETANUS 14
Complications:
5/11/2012 Disease Presentation- TETANUS 15
 Acute asphyxia
 Aspiration pneumonia
 Respiratory arrest
 Vertebral fracture
 Laceration of tongue, lips, buccal cavity.
Control and Prevention:
 Tetanus is a vaccine preventable
disease.
 Immunization of mother with 2
doses of TT during 2nd trimester of
pregnancy can prevent Neonatal
tetanus.
 Infants & children should be
immunized by primary active
immunization with DPT at 6, 10,14
weeks.
5/11/2012 Disease Presentation- TETANUS 16
Control and prevention:
 immunize the vulnerable groups such as all industrial,
agricultural workers, armed forces etc.
 Early treatment of wound/ injury and give injection tetanus
toxoid.
 Use of early antibiotics.
 3 clean during delivery;
Clean hand
Clean delivery surface
Clean cord care.
5/11/2012 Disease Presentation- TETANUS 17
Control and prevention:
5/11/2012 Disease Presentation- TETANUS 18
• Give proper health education about tetanus such as
preventive measures, effects, etc.
• Provide awareness that it can be prevented by post-
exposure prophylaxis.
•Active immunization shall protect all over them for 10
years that means adults should receive a booster
vaccine every ten years.
PICTURES OF CHILDREN SUFFERING FROM
TETANUS:
5/11/2012 Disease Presentation- TETANUS 19
Children and adult man;
5/11/2012 Disease Presentation- TETANUS 20
Picture of Suffering dog;
5/11/2012 Disease Presentation- TETANUS 21
REFERENCES :
 www.google.com
 www.wekepedia.org
 A book of preventive and social medicine by K. park
 A test book of clinical medicine for health science by
Dr. tilak pathak.
 Oxford journal of public health vol:31
5/11/2012 Disease Presentation- TETANUS 22
THANK YOU………
5/11/2012 Disease Presentation- TETANUS 23
tetanus-120511152528-phpapp0.        .pptx

More Related Content

Similar to tetanus-120511152528-phpapp0. .pptx

Tetanus- Introduction and Its epidemiology in Nepal
Tetanus- Introduction and Its epidemiology in NepalTetanus- Introduction and Its epidemiology in Nepal
Tetanus- Introduction and Its epidemiology in NepalKapil Sharma Neupane
 
Tetanus and Anaerobic infection
Tetanus and Anaerobic infectionTetanus and Anaerobic infection
Tetanus and Anaerobic infectionEneutron
 
Tetanus |Causes | Signs and symptoms| All aspects - medical discussion
Tetanus |Causes | Signs and symptoms| All aspects - medical discussion Tetanus |Causes | Signs and symptoms| All aspects - medical discussion
Tetanus |Causes | Signs and symptoms| All aspects - medical discussion martinshaji
 
Surface Infections4-WPS Office.pptx
Surface Infections4-WPS Office.pptxSurface Infections4-WPS Office.pptx
Surface Infections4-WPS Office.pptxSudipta Roy
 
routine immunization in india( from gov.in) .ppt
routine immunization in india( from gov.in) .pptroutine immunization in india( from gov.in) .ppt
routine immunization in india( from gov.in) .pptSauravKumar927915
 
Surface infection
Surface infectionSurface infection
Surface infectiontulu2015
 
Universal Immunization Program 2017
Universal Immunization Program 2017Universal Immunization Program 2017
Universal Immunization Program 2017Annu verma
 

Similar to tetanus-120511152528-phpapp0. .pptx (20)

!Tetanus m
!Tetanus m!Tetanus m
!Tetanus m
 
Tetanus also called: lockjaw
Tetanus also called: lockjawTetanus also called: lockjaw
Tetanus also called: lockjaw
 
Tetanus- Introduction and Its epidemiology in Nepal
Tetanus- Introduction and Its epidemiology in NepalTetanus- Introduction and Its epidemiology in Nepal
Tetanus- Introduction and Its epidemiology in Nepal
 
Tetanus in children Dr. ozil
Tetanus in children  Dr. ozilTetanus in children  Dr. ozil
Tetanus in children Dr. ozil
 
Tetanus and Anaerobic infection
Tetanus and Anaerobic infectionTetanus and Anaerobic infection
Tetanus and Anaerobic infection
 
Tetanus
TetanusTetanus
Tetanus
 
TETANUS
TETANUSTETANUS
TETANUS
 
Tetanus.ppt
Tetanus.pptTetanus.ppt
Tetanus.ppt
 
Tetanus |Causes | Signs and symptoms| All aspects - medical discussion
Tetanus |Causes | Signs and symptoms| All aspects - medical discussion Tetanus |Causes | Signs and symptoms| All aspects - medical discussion
Tetanus |Causes | Signs and symptoms| All aspects - medical discussion
 
titnass.pptx
titnass.pptxtitnass.pptx
titnass.pptx
 
Tetanus
TetanusTetanus
Tetanus
 
Tetanus
TetanusTetanus
Tetanus
 
Surface Infections4-WPS Office.pptx
Surface Infections4-WPS Office.pptxSurface Infections4-WPS Office.pptx
Surface Infections4-WPS Office.pptx
 
Tetanus
TetanusTetanus
Tetanus
 
Tetanus
TetanusTetanus
Tetanus
 
tetanus.pptx
tetanus.pptxtetanus.pptx
tetanus.pptx
 
routine immunization in india( from gov.in) .ppt
routine immunization in india( from gov.in) .pptroutine immunization in india( from gov.in) .ppt
routine immunization in india( from gov.in) .ppt
 
Tetanus
TetanusTetanus
Tetanus
 
Surface infection
Surface infectionSurface infection
Surface infection
 
Universal Immunization Program 2017
Universal Immunization Program 2017Universal Immunization Program 2017
Universal Immunization Program 2017
 

More from DebdattaMandal5

tb prevention..........................ppt
tb prevention..........................ppttb prevention..........................ppt
tb prevention..........................pptDebdattaMandal5
 
Renal function Tests - PPT..........pptx
Renal function Tests - PPT..........pptxRenal function Tests - PPT..........pptx
Renal function Tests - PPT..........pptxDebdattaMandal5
 
Body fluid..........................pptx
Body fluid..........................pptxBody fluid..........................pptx
Body fluid..........................pptxDebdattaMandal5
 
renalfunctiontests-130723211756-phpapp01.pptx
renalfunctiontests-130723211756-phpapp01.pptxrenalfunctiontests-130723211756-phpapp01.pptx
renalfunctiontests-130723211756-phpapp01.pptxDebdattaMandal5
 
Imaging of the Renal System..........ppt
Imaging of the Renal System..........pptImaging of the Renal System..........ppt
Imaging of the Renal System..........pptDebdattaMandal5
 
DOC-20230308-WA0008.................pptx
DOC-20230308-WA0008.................pptxDOC-20230308-WA0008.................pptx
DOC-20230308-WA0008.................pptxDebdattaMandal5
 
labdiagnosisinrenaldiseases-copy-180611071550.pptx
labdiagnosisinrenaldiseases-copy-180611071550.pptxlabdiagnosisinrenaldiseases-copy-180611071550.pptx
labdiagnosisinrenaldiseases-copy-180611071550.pptxDebdattaMandal5
 
kidneydisorders-151105065618-lva1-app6892.ppt
kidneydisorders-151105065618-lva1-app6892.pptkidneydisorders-151105065618-lva1-app6892.ppt
kidneydisorders-151105065618-lva1-app6892.pptDebdattaMandal5
 
introductionadministrationmanagement-170719152235.pptx
introductionadministrationmanagement-170719152235.pptxintroductionadministrationmanagement-170719152235.pptx
introductionadministrationmanagement-170719152235.pptxDebdattaMandal5
 
multiple pregnancy....................pptx
multiple pregnancy....................pptxmultiple pregnancy....................pptx
multiple pregnancy....................pptxDebdattaMandal5
 
hypertensivedisordersofpregnancy-180930162838.pptx
hypertensivedisordersofpregnancy-180930162838.pptxhypertensivedisordersofpregnancy-180930162838.pptx
hypertensivedisordersofpregnancy-180930162838.pptxDebdattaMandal5
 
epidemiology-16062704353..........4.pptx
epidemiology-16062704353..........4.pptxepidemiology-16062704353..........4.pptx
epidemiology-16062704353..........4.pptxDebdattaMandal5
 
epidemiologypreventionandcontrolofplague-160627043327.pptx
epidemiologypreventionandcontrolofplague-160627043327.pptxepidemiologypreventionandcontrolofplague-160627043327.pptx
epidemiologypreventionandcontrolofplague-160627043327.pptxDebdattaMandal5
 
typhoidfeverppt-1812021.......24043.pptx
typhoidfeverppt-1812021.......24043.pptxtyphoidfeverppt-1812021.......24043.pptx
typhoidfeverppt-1812021.......24043.pptxDebdattaMandal5
 
tetanus-1205111525..28-phpapp02 (2).pptx
tetanus-1205111525..28-phpapp02 (2).pptxtetanus-1205111525..28-phpapp02 (2).pptx
tetanus-1205111525..28-phpapp02 (2).pptxDebdattaMandal5
 
poliomyelitis-1908102.........00943.pptx
poliomyelitis-1908102.........00943.pptxpoliomyelitis-1908102.........00943.pptx
poliomyelitis-1908102.........00943.pptxDebdattaMandal5
 
covidvaccines-210821171459...........pptx
covidvaccines-210821171459...........pptxcovidvaccines-210821171459...........pptx
covidvaccines-210821171459...........pptxDebdattaMandal5
 
covid-200424062237..................pptx
covid-200424062237..................pptxcovid-200424062237..................pptx
covid-200424062237..................pptxDebdattaMandal5
 
meningitis-170131181426888888888888.pptx
meningitis-170131181426888888888888.pptxmeningitis-170131181426888888888888.pptx
meningitis-170131181426888888888888.pptxDebdattaMandal5
 
whooping cough lecture...............ppt
whooping cough lecture...............pptwhooping cough lecture...............ppt
whooping cough lecture...............pptDebdattaMandal5
 

More from DebdattaMandal5 (20)

tb prevention..........................ppt
tb prevention..........................ppttb prevention..........................ppt
tb prevention..........................ppt
 
Renal function Tests - PPT..........pptx
Renal function Tests - PPT..........pptxRenal function Tests - PPT..........pptx
Renal function Tests - PPT..........pptx
 
Body fluid..........................pptx
Body fluid..........................pptxBody fluid..........................pptx
Body fluid..........................pptx
 
renalfunctiontests-130723211756-phpapp01.pptx
renalfunctiontests-130723211756-phpapp01.pptxrenalfunctiontests-130723211756-phpapp01.pptx
renalfunctiontests-130723211756-phpapp01.pptx
 
Imaging of the Renal System..........ppt
Imaging of the Renal System..........pptImaging of the Renal System..........ppt
Imaging of the Renal System..........ppt
 
DOC-20230308-WA0008.................pptx
DOC-20230308-WA0008.................pptxDOC-20230308-WA0008.................pptx
DOC-20230308-WA0008.................pptx
 
labdiagnosisinrenaldiseases-copy-180611071550.pptx
labdiagnosisinrenaldiseases-copy-180611071550.pptxlabdiagnosisinrenaldiseases-copy-180611071550.pptx
labdiagnosisinrenaldiseases-copy-180611071550.pptx
 
kidneydisorders-151105065618-lva1-app6892.ppt
kidneydisorders-151105065618-lva1-app6892.pptkidneydisorders-151105065618-lva1-app6892.ppt
kidneydisorders-151105065618-lva1-app6892.ppt
 
introductionadministrationmanagement-170719152235.pptx
introductionadministrationmanagement-170719152235.pptxintroductionadministrationmanagement-170719152235.pptx
introductionadministrationmanagement-170719152235.pptx
 
multiple pregnancy....................pptx
multiple pregnancy....................pptxmultiple pregnancy....................pptx
multiple pregnancy....................pptx
 
hypertensivedisordersofpregnancy-180930162838.pptx
hypertensivedisordersofpregnancy-180930162838.pptxhypertensivedisordersofpregnancy-180930162838.pptx
hypertensivedisordersofpregnancy-180930162838.pptx
 
epidemiology-16062704353..........4.pptx
epidemiology-16062704353..........4.pptxepidemiology-16062704353..........4.pptx
epidemiology-16062704353..........4.pptx
 
epidemiologypreventionandcontrolofplague-160627043327.pptx
epidemiologypreventionandcontrolofplague-160627043327.pptxepidemiologypreventionandcontrolofplague-160627043327.pptx
epidemiologypreventionandcontrolofplague-160627043327.pptx
 
typhoidfeverppt-1812021.......24043.pptx
typhoidfeverppt-1812021.......24043.pptxtyphoidfeverppt-1812021.......24043.pptx
typhoidfeverppt-1812021.......24043.pptx
 
tetanus-1205111525..28-phpapp02 (2).pptx
tetanus-1205111525..28-phpapp02 (2).pptxtetanus-1205111525..28-phpapp02 (2).pptx
tetanus-1205111525..28-phpapp02 (2).pptx
 
poliomyelitis-1908102.........00943.pptx
poliomyelitis-1908102.........00943.pptxpoliomyelitis-1908102.........00943.pptx
poliomyelitis-1908102.........00943.pptx
 
covidvaccines-210821171459...........pptx
covidvaccines-210821171459...........pptxcovidvaccines-210821171459...........pptx
covidvaccines-210821171459...........pptx
 
covid-200424062237..................pptx
covid-200424062237..................pptxcovid-200424062237..................pptx
covid-200424062237..................pptx
 
meningitis-170131181426888888888888.pptx
meningitis-170131181426888888888888.pptxmeningitis-170131181426888888888888.pptx
meningitis-170131181426888888888888.pptx
 
whooping cough lecture...............ppt
whooping cough lecture...............pptwhooping cough lecture...............ppt
whooping cough lecture...............ppt
 

Recently uploaded

Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxRoyAbrique
 

Recently uploaded (20)

Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
 

tetanus-120511152528-phpapp0. .pptx

  • 1. TETANUS Prepared by: SAgun PAudel Health Assistant Student of BPH @ LA GRANDEE International college, Simalchour Pokhara, Nepal Presented with: Rajeev Nepal 5/11/2012 Disease Presentation- TETANUS 1
  • 2. Definition: 5/11/2012 Disease Presentation- TETANUS 2 Tetanus is a acute bacterial disease caused by the neurotoxin tetanospasmin elaborated by Clostridium tetani. and characterized by a prolonged contraction of skeletal muscle fibers. It is also called lockjaw.
  • 3. Causative organism:  Clostridium tetani is a Gram-positive, obligate anaerobic, spore bearing and flagellate organism.  produce a potent exotoxin called tetanospasmin. spores are resistant to heat and most antiseptics. 5/11/2012 Disease Presentation- TETANUS 3
  • 4. epidemiology: 5/11/2012 Disease Presentation- TETANUS 4  Tetanus is an international health problem, as spores are ubiquitous. The disease occurs almost exclusively in persons who are unvaccinated or inadequately immunized.  Tetanus occurs worldwide but is more common in hot, damp climates with soil rich in organic matter.  More common in developing and under developing countries.  More prevalent in industrial establishment, where agricultures workers are employed.  Tetanus neonatorum is common due to lack of MCH care.
  • 5. Global burden: 5/11/2012 Disease Presentation- TETANUS 5  Tetanus, particularly the neonatal form a significant public health problem in non-industrialized countries.  The World Health Organization estimates that 59,000 newborns worldwide died in 2008 as a result of neonatal tetanus.
  • 6. In Nepal : 5/11/2012 Disease Presentation- TETANUS 6  In late 2005,Nepal demonstrated through surveys that it had reached the WHO criterion for having eliminated neonatal tetanus, i.e. NT cases occurred at a rate of less than 1 per 1000 live births in every district. Strategies:  clean delivery  routine immunization  supplemental immunization campaigns  surveillance
  • 7. Some facts; 5/11/2012 Disease Presentation- TETANUS 7  Initiation of EPI in 1979 [3 districts]  1989 in 75 districts  DPT and TT vaccines from 1981. years TT+2 COVERAGE 1993–1995 33% 1996–2000 45% 1999 65%
  • 8. INCUBATION PERIOD: 5/11/2012 Disease Presentation- TETANUS 8  Usually incubation period ranges from 3-21 days but can range from the day of injury to several months.  Average incubation period is 10 days.  Depends on character, location, and extent of wound.
  • 9. Mode of transmission: 5/11/2012 Disease Presentation- TETANUS 9  Infection is acquired by contamination of wounds with Clostridium tetani spores. a tiny breach in skin or mucosa (e.g.. Skin abrasion, punctured wounds, burns, animal bites, unsterile surgery, aseptic abortion, unsterile instruments to cut umbilical cord etc.) leads to introduce of spores.  the spores are widely distributed in the intestines and faeces of many non-human animals such as horses, sheep, cattle, dogs, cats, rats, guinea pigs, and chickens.  Tetanus is not spread from person to person.
  • 10. Pathogenesis: 5/11/2012 Disease Presentation- TETANUS 10  Tetanus begins when spores of Clostridium tetani enter damaged tissue. The spores transform into rod-shaped bacteria and produce the neurotoxin tetanospasmin (also known as tetanus toxin). This toxin is inactive inside the bacteria, but when the bacteria die, toxin is released and activated by proteases. Finally it interferes with neurotransmission at spinal synapses of inhibitory neurons. This results to uncontrolled spasms and reflexes.
  • 11. Clinical features:  Pain and tingling at the site of wound.  Pain in neck, back and abdomen.  Opisthotonos position.  Risus sardonicus (Mouth kept slightly open)  Spasm of pharyngeal muscles.  Lock jaw (reflex trismus).  Dysphasia.  Acute asphyxia.  Refusal of feeding and excessive crying.  Other symptoms like fever, headache, etc 5/11/2012 Disease Presentation- TETANUS 11
  • 12. Diagnosis: 5/11/2012 Disease Presentation- TETANUS 12  There are currently no blood tests that can be used to diagnose tetanus.  clinical presentation of patient associated with tetanus are the essential factors of diagnosis.  history of injury and possible contamination.
  • 13. Treatment: 5/11/2012 Disease Presentation- TETANUS 13  Injection tetanus toxoid 0.5ml intramuscularly.  Passive immunization with human anti - tetanospasmin immunoglobulin.  Local wound care: o Incision & drainage of pus. o Debridement (Removal of necrotic tissues & foreign bodies) o Wound should be open.
  • 14. Treatment:  Control of spasm: o Injection diazepam 0.1-0.2mg/ kg. o Paralyze & ventilate.  Antibiotics: o Broad spectrum antibiotics to treat or prevent infection.  Supportive care: o Isolation in a quit dark room. o Maintain fluid, nutrition, and electrolytes. o Oxygen inhalation if required. 5/11/2012 Disease Presentation- TETANUS 14
  • 15. Complications: 5/11/2012 Disease Presentation- TETANUS 15  Acute asphyxia  Aspiration pneumonia  Respiratory arrest  Vertebral fracture  Laceration of tongue, lips, buccal cavity.
  • 16. Control and Prevention:  Tetanus is a vaccine preventable disease.  Immunization of mother with 2 doses of TT during 2nd trimester of pregnancy can prevent Neonatal tetanus.  Infants & children should be immunized by primary active immunization with DPT at 6, 10,14 weeks. 5/11/2012 Disease Presentation- TETANUS 16
  • 17. Control and prevention:  immunize the vulnerable groups such as all industrial, agricultural workers, armed forces etc.  Early treatment of wound/ injury and give injection tetanus toxoid.  Use of early antibiotics.  3 clean during delivery; Clean hand Clean delivery surface Clean cord care. 5/11/2012 Disease Presentation- TETANUS 17
  • 18. Control and prevention: 5/11/2012 Disease Presentation- TETANUS 18 • Give proper health education about tetanus such as preventive measures, effects, etc. • Provide awareness that it can be prevented by post- exposure prophylaxis. •Active immunization shall protect all over them for 10 years that means adults should receive a booster vaccine every ten years.
  • 19. PICTURES OF CHILDREN SUFFERING FROM TETANUS: 5/11/2012 Disease Presentation- TETANUS 19
  • 20. Children and adult man; 5/11/2012 Disease Presentation- TETANUS 20
  • 21. Picture of Suffering dog; 5/11/2012 Disease Presentation- TETANUS 21
  • 22. REFERENCES :  www.google.com  www.wekepedia.org  A book of preventive and social medicine by K. park  A test book of clinical medicine for health science by Dr. tilak pathak.  Oxford journal of public health vol:31 5/11/2012 Disease Presentation- TETANUS 22
  • 23. THANK YOU……… 5/11/2012 Disease Presentation- TETANUS 23